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Abstract
Purpose: It has been shown that a cataract significantly reduces mfERG responses in the central 4–14.
Removing the cataract, leads to a significant increase in the response of the central 4. In this study we
compare the mfERG of Woerdehoff et al.’s patients’ [Doc Ophthalmol 2004; 108(1): 67–75] following
cataract surgery to a healthy control group in order to assess whether, in the elderly, further influences of
age need to be considered in addition to optical effects.Methods: Eighteen patients with an IOL following
cataract surgery and 29 healthy volunteers (without clouding of the media or retinal changes) underwent
testing of the mfERG (103 hexagons stimulating the central 50, M-sequence 215, Lmax: 200 cd/m2, Lmin
<1 cd/m2). For the ﬁrst order response component we compared the latencies of N1,P1 and N2 as well as
the natural logarithm (ln) of the amplitudes N1P1 and P1N2 for four group averages: I. the central 4, II.
4–7, III. 7–10 and IV. 10–15. Results: Mean age was 67 years (SD 10.1) for the IOL patients, 28.5 years
(SD 5.6) for a young group of controls (n=15) and 60.2 years (SD 9.2) for the older control group (n=14).
Patients with an IOL did not differ in latency from either control group (ANOVA, Tukey). Interestingly, at
10–15 eccentricity, the latency of N2 differed significantly between the younger (41.4 ms, SD 1.4) and the
older (43.0 ms, SD 1.9) control group. In the central 4 LnN1P1 amplitudes were significantly lower in the
IOL group (mean: 3.7, SD 0.2) than either the younger (mean: 3.9, SD 3.3) or the older (mean: 4.0, SD 0.3)
control group. In all other amplitude measures, the older control group had slightly larger mean amplitudes
than the younger control group and significantly larger amplitudes than the patients with an IOL, whose
amplitudes were lowest. Discussion: Both, primarily optical but also neural phenomena have been de-
scribed to affect the mfERG changes observed with age. Our results, are in support of this, as the
improvement of the mfERG response following cataract surgery does not seem to reach the level of a
healthy control group of equal age. Thus, our results suggest, that a control group with an IOL should be
used when retinal function is tested in subjects with an IOL.
Introduction
It has recently been shown that a cataract signifi-
cantly reduces mfERG responses in the central
4–14 [1, 2]. On the other hand, removing the
cataract, leads to a signiﬁcant increase in the re-
sponse of the central 4 [1]. This suggests, that
following cataract extraction, the mfERG may
recover to normal values. If this were the case,
the mfERG in patients with a retinal problem
who happen to have an IOL might be compared
to a healthy control group, although it needs to
be determined, whether this control group would
have to be age matched, as recent literature con-
tains conﬂicting reports on the inﬂuence of age
on the mfERG: While some report no change
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with age [3], most studies report a reduction in
amplitudes with or without an increase in laten-
cies [4–11]. These age related changes have been
thought to occur primarily as a result of an
increasing lens opacity with age [7]. However,
others have suggested neural changes to be addi-
tionally involved in these effects[6].
In this study we therefore compare the
mfERG of pseudophake [1] to an age matched as
well as to a younger healthy control group in or-
der to assess whether, in the elderly with an IOL,
further inﬂuences of age need to be considered in
addition to optical effects.
Methods
Eighteen pseudophake patients and 29 healthy
volunteers underwent testing of the mfERG.
Mean age was 67 years (SD 10.1) for the IOL
patients, 28.5 years (SD 5.6) for a young group
of controls (n=15) and 60.2 years (SD 9.2) for
the older control group (n=14). Visual acuity
was over 0.8 in patients with an IOL and 1.0 in
the control group.
In either patients or subjects, inclusion criteria
included the absence of clouding of the optic med-
ia, other eye disease, such as glaucoma, or systemic
diseases that might affect the mfERG recording,
such as diabetes mellitus, as well as refractive errors
exceeding 6 dioptres spherical correction and
3 dioptres astigmatic correction. No previous eye
surgery – other than the cataract surgery in patients-
had been performed in the eyes recorded from.
Patients with an IOL were taken from the
study of Woerdehoff et al. [1]. In these patients,
the mfERG was recorded prior to and at least
6 weeks following cataract surgery. Patient pt15
who suffered from retinal dysfunction secondary
to an eye trauma was excluded. Three patients
received a multifocal IOL, while the others re-
ceived a monofocal IOL.
In patients the eye undergoing cataract sur-
gery was included. In 14 patients this was the
right eye, in 4 the left eye. In the control subjects
the right eye was included, unless it did not fulfil
the inclusion criteria. In this case the patients’
left eye was included (n=2).
In agreement with the declaration of Helsinki,
approval from the ethic comittee had been ob-
tained and participants had given their informed
consent in writing.
MfERGs were recorded with VERIS sci-
enceTM (EDI, San Mateo, California) using a
Burian- Allen bipolar contact lens electrode. The
stimulus was presented on a monochrome moni-
tor. During recording, 103 hexagons stimulated
the central 50 of the retina. Hexagons were
scaled with eccentricity to take into account the
distribution of retinal cones in this area. Hexa-
gons ﬂickered between light (Lmax: 200 cd/m
2)
and dark (Lmin<1 cd/m
2) according to an M-se-
quence of 215 [12]. An artefact elimination tech-
nique was applied once [12]. Individual responses
were not additionally averaged with their neigh-
bouring responses.
For the first order response component we
compared the latencies of N1, P1 and N2 as well
Figure 1. (a) Shows the area of the responses that were averaged for analysis: I. the central 4, II. 4–7, III. 7–10 and IV. 10–15.
(b Depicts a typical waveform of the ﬁrst order response. For the ﬁrst order response component we compared the latencies of
N1,P1 and N2 as well as the natural logarithm (ln) of the amplitudes of N1P1 and P1N2 for the four group averages shown in 1a.
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as the amplitudes of N1P1 and P1N2 for four
group averages: I. the central 4, II. 4–7, III. 7–
10 and IV. 10–15. Figure 1 demonstrates the
area of the responses that were averaged for
analysis (Figure 1a) as well as a waveform show-
ing N1, P1 and N2 (1b). As amplitudes are not
normally distributed, they were normalized using
the natural logarithm (ln).
For statistical analysis an ANOVA was per-
formed, followed by a Tukey post hoc test. The
resulting p-value was considered significant if it
was below 0.05.
Results
Tables 1 and 2 show the resulting mean ampli-
tudes and latencies and their corresponding stan-
dard deviation, while Figure 2 allows comparison
of the ln amplitudes (Figure 2a and b) as well as
of the latencies (Figure 2c).
Latencies did not differ between the pseud-
ophake patients and the control groups (ANO-
VA, Tukey). Interestingly, between the younger
and the older control group the latency of N2
differed significantly at 10–15 eccentricity
(p=0.032). Here the mean latency of N2 was
41.4 ms (SD 1.4) in the younger control group
and 43.0 ms (SD 1.9) in the older control group
(Table 2. Figure 2c). This compared to a mean
latency of N2 of 42.5 ms (SD 1.7) in the pseud-
ophake patients.
Amplitudes in the central 4 LnN1P1 (natural
log) were lower in the IOL group (mean: 3.7, SD
0.2) than either the younger (mean: 3.9 (SD 3.3),
p= 0.043) or the older control group (mean: 4.0
(SD 0.3), p=0.006).
In all other amplitude measures, the older
control group had slightly larger mean ampli-
tudes than the younger control group and signifi-
cantly larger amplitudes than the patients with
an IOL, whose amplitudes were lowest (Table 1,
Table 1. Shows the mean amplitudes and their corresponding standard deviation for a young control group aged 20–40 years, for
an older control group aged 41–72 years and for the patients with an IOL
Amplitudes (nV/deg2)
Group average I Group average II Group average III Group average IV
N1P1 P1N2 N1P1 P1N2 N1P1 P1N2 N1P1 P1N2
Control 20–40 Mean 57.5267 60.2667 37.8067 40.1400 29.0133 30.6533 22.7467 23.4933
SD 21.8772 24.4176 17.7857 19.7598 13.6608 15.3024 11.5265 12.7517
Control 41–72 Mean 63.6214 74.5357 41.4357 49.1643 31.6000 38.0429 26.9357 30.4000
SD 25.2789 32.8338 14.4032 18.9055 10.9400 13.9845 8.5732 10.6426
IOL Mean 41.7294 46.8176 28.3059 31.1353 22.4882 24.1353 18.6118 18.9000
SD 9.2089 12.8117 6.7110 8.3192 5.6337 6.5400 5.2315 5.5677
Table 2. Depicts the mean latencies and their corresponding standard deviation for a young control group aged 20–40 years, for
an older control group aged 41–72 years and for the patients with an IOL
Latencies (ms)
Group average I Group average II Group average III Group average IV
N1 P1 N2 N1 P1 N2 N1 P1 N2 N1 P1 N2
Control 20–40 Mean 15.2333 28.4867 44.2067 14.4933 27.5600 41.9800 14.2733 27.1067 41.4067 14.5000 27.1667 41.4267
SD 1.1574 1.3907 1.4602 0.9331 1.3984 1.5758 0.9903 1.3392 1.6455 0.8194 1.4505 1.4210
Control 41–72 Mean 15.9000 29.3357 45.6714 14.7429 28.5071 43.4214 14.6429 28.1071 42.6500 15.1071 28.4500 43.0643
SD 1.3342 1.5805 1.8433 1.1921 1.3205 1.5846 1.1036 1.6836 1.4179 1.0299 1.5356 1.9274
IOL Mean 15.2941 28.6647 44.7824 14.1176 27.8412 42.5294 13.8647 27.2588 41.8824 14.7529 27.9824 42.4765
SD 1.0201 1.1152 1.8294 0.9983 1.3933 1.7367 1.0612 1.5500 1.8256 0.8581 1.8782 1.7452
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Figures 2a and b). Signiﬁcant amplitude differ-
ences are listed below: In the central 4, mean
LnP1N2 was 4.23 in the older control group and
3.81 in the IOL patients (p=0.005, Tukey). Be-
tween 4 and 7 mean LnN1P1 was 3.67 in the
older control group and 3.31 in the IOL patients
(p=0.013, Tukey), while mean LnP1N2 was 3.83
in the older control group and 3.4 in the IOL pa-
tients (p=0.005, Tukey). From 7 to 10 mean
LnN1P1 was 3.4 in the older control group and
3.08 in the IOL patients (p=0.029, Tukey), while
mean LnP1N2 was 3.58 in the older control
group and 3.14 in the IOL patients (p= 0.005,
Tukey). In the outer 10–15 mean LnN1P1 was
3.25 in the older control group and 2.88 in the
IOL patients (p=0.022, Tukey), while mean
LnP1N2 was 3.36 in the older control group and
2.89 in the IOL patients (p=0.006, Tukey).
The slight difference in age had no significant
influence on the statistical outcome (ANOVA).
Figure 2. The boxplots in (a–c) show the ln amplitudes of N1P1 (a) and P1N2 (b) as well as the latencies of N1, P1 and N2 (c) for
a young control group aged 20–40 years, an older control group aged 41–72 years and for the patients with an IOL. The error bars
represent ±2 standard errors of the mean. Non-overlap between 2 SEs of adjacent means implies a signiﬁcant difference at the 5%
level (p<0.05). The values in the ln amplitude plots are the mean ln amplitude values.
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Discussion
Both, primarily optical but also neural phenom-
ena have been described to affect the mfERG
changes observed with age [6, 7]. In this context,
response density is thought to be more inﬂuenced
by optical factors while P1 implicit time changes
are more inﬂuenced by neural factors [6].
If clearness of the optical axis alone were to
account for the changes in the mfERG observed
with age [4–11], patients with clear optical media
should have mfERG responses comparable to a
young healthy control group. Thus, with an IOL,
the responses should also be better (amplitudes
higher and latencies longer) than those of an age
matched control group, where the lens is known
to increase in density with age [13].
Another optical factor that needs to be taken
into account is that IOLs generally transmit more
blue light than the natural lens [14]. The phosphor
used in our monochromatic monitor has a double
peaked spectral energy distribution with one peak
at around 450 nm and a second peak at around
550 nm. A recent study showed that ﬂashes of
Figure 2. Continued
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blue, green or white light produce a photopic hill
response with an almost identical amplitude
(Vmax) [15]. Thus it might be expected that follow-
ing cataract surgery, the increase in blue light
transmittance would cause an increase in ampli-
tude in the patients with an IOL. However, the
improvement seen in the central mfERG response
following cataract surgery [1] did not even reach
the level of a healthy control group of equal age.
Recently intravitreal surgery with peeling of
the internal limiting membrane has been shown
to have no effect on inner or outer retinal func-
tion of the mfERG [16]. Therefore, a reduction
in macular function secondary to the surgical
light exposure also seems unlikely as a cause of
the reduction in amplitude observed in this
study.
The slight difference in visual acuity alone
would also not account for the reduced ampli-
tudes seen in the pseudophakes. A previous study
showed that optical degradation through plus- or
minus-lenses did not result in changes in the
mfERG of healthy subjects [17]. Also, there is no
direct relation between visual acuity and the
amplitudes of the mfERG, as the mfERG re-
sponses are an averaged response over a retinal
area of various size, whereas visual acuity is de-
ﬁned by the function of a few central photore-
ceptors.
Thus, as optical factors alone cannot explain
the mfERG changes observed, our results, are in
support of neural factors in addition to optical
factors influencing mfERG changes in patients
with an IOL.
In our study, amplitudes tended to be slightly
higher in our older than in our younger control
group. This may present either a selection bias or
represent a biological advantage in these older
subjects without age related diseases.
Our findings of high amplitudes in the elderly
is in contrast to previous findings that show
amplitudes to decrease with age [4–11]. However,
the inclusion criteria for elderly subjects differ
between these studies. As an example, patients
with upto ﬁve small drusen were included in one
study [11], while another allowed a visual acuity
of 0.8 or higher [10]. This makes it difﬁcult to
compare subject populations, as it is known, that
for example drusen affect the mfERG response
[18, 19]. Thus the population in elderly control
subjects may differ between studies.
Patients with a cataract are known to have an
increased risk of developing other age related dis-
eases such as artherosclerosis [20] or age related
macular degeneration [21], suggesting that pa-
tients with a cataract may age faster and thus
have a greater likelihood of being affected by
subclinical retinal pathology. In comparison, this
would mean, that older patients without a cata-
ract are likely to age slower. Thus our elderly
control group consisting of subjects with clini-
cally very clear lenses and no retinal abnormali-
ties may have a biological advantage.
Thus, our results suggest, that a control
group with an IOL should be used when retinal
function is tested in subjects with an IOL.
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